There's a bifurcation in healthcare: the companies that are fighting COVID-19, and the companies that are not. Many of the stocks of the former have zoomed higher. But others have seen delays in their business, and COVID-19 has hurt these stocks. Some of these companies are real bargains now.
Three Fool.com contributors like pulmonary specialist Pulmonx (NASDAQ: LUNG) , Vertex Pharmaceuticals (NASDAQ: VRTX) , and Axsome Therapeutics (NASDAQ: AXSM) . Read on to see why these three stocks might crush the market over the next few years.
Image source: Getty Images.
For further details see:
3 Healthcare Stocks That Might Skyrocket When COVID Is Over